Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer

Lakshmi Prabhu, Rasika Mundade, Benlian Wang, Han Wei, Antja Voy Hartley, Matthew Martin, Kyle McElyea, Constance J. Temm, George Sandusky, Yunlong Liu, Tao Lu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Y-box binding protein 1 [YBX1] is a multifunctional protein known to facilitate many of the hallmarks of cancer. Elevated levels of YBX1 protein are highly correlated with cancer progression, making it an excellent marker in cancer. The connection between YBX1 and the important nuclear factor κB [NF-κB] has never been reported. Here, we show that overexpression of wild type YBX1 [WT-YBX1] activates NF-κB, suggesting that YBX1 is a potential NF-κB activator. Furthermore, using mass spectrometry analysis we identified novel phosphorylation of serine 165 [S165] on YBX1. Overexpression of the S165A-YBX1 mutant in either HEK293 cells or colon cancer HT29 cells showed dramatically reduced NF-κB activating ability as compared with that of WT-YBX1, confirming that S165 phosphorylation is critical for the activation of NF-κB by YBX1. We also show that expression of the S165A-YBX1 mutant dramatically decreased the expression of NF-κB-inducible genes, reduced cell growth, and compromised tumorigenic ability as compared with WT-YBX1. Taken together, we provide the first evidence that YBX1 functions as a tumor promoter via NF-κB activation, and phosphorylation of S165 of YBX1 is critical for this function. Therefore, our important discovery may lead to blocking S165 phosphorylation as a potential therapeutic strategy to treat colon cancer.

Original languageEnglish (US)
Pages (from-to)29396-29412
Number of pages17
JournalOncotarget
Volume6
Issue number30
DOIs
StatePublished - 2015

Fingerprint

Y-Box-Binding Protein 1
Colonic Neoplasms
Serine
Phosphorylation
Neoplasms
HT29 Cells
HEK293 Cells
Carcinogens

Keywords

  • Colon cancer
  • NF-κB
  • Phosphorylation
  • Serine
  • YBX1

ASJC Scopus subject areas

  • Oncology

Cite this

Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer. / Prabhu, Lakshmi; Mundade, Rasika; Wang, Benlian; Wei, Han; Hartley, Antja Voy; Martin, Matthew; McElyea, Kyle; Temm, Constance J.; Sandusky, George; Liu, Yunlong; Lu, Tao.

In: Oncotarget, Vol. 6, No. 30, 2015, p. 29396-29412.

Research output: Contribution to journalArticle

Prabhu, L, Mundade, R, Wang, B, Wei, H, Hartley, AV, Martin, M, McElyea, K, Temm, CJ, Sandusky, G, Liu, Y & Lu, T 2015, 'Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer', Oncotarget, vol. 6, no. 30, pp. 29396-29412. https://doi.org/10.18632/oncotarget.5120
Prabhu, Lakshmi ; Mundade, Rasika ; Wang, Benlian ; Wei, Han ; Hartley, Antja Voy ; Martin, Matthew ; McElyea, Kyle ; Temm, Constance J. ; Sandusky, George ; Liu, Yunlong ; Lu, Tao. / Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer. In: Oncotarget. 2015 ; Vol. 6, No. 30. pp. 29396-29412.
@article{ec20f8be61bd443aa7483de119ee2903,
title = "Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer",
abstract = "Y-box binding protein 1 [YBX1] is a multifunctional protein known to facilitate many of the hallmarks of cancer. Elevated levels of YBX1 protein are highly correlated with cancer progression, making it an excellent marker in cancer. The connection between YBX1 and the important nuclear factor κB [NF-κB] has never been reported. Here, we show that overexpression of wild type YBX1 [WT-YBX1] activates NF-κB, suggesting that YBX1 is a potential NF-κB activator. Furthermore, using mass spectrometry analysis we identified novel phosphorylation of serine 165 [S165] on YBX1. Overexpression of the S165A-YBX1 mutant in either HEK293 cells or colon cancer HT29 cells showed dramatically reduced NF-κB activating ability as compared with that of WT-YBX1, confirming that S165 phosphorylation is critical for the activation of NF-κB by YBX1. We also show that expression of the S165A-YBX1 mutant dramatically decreased the expression of NF-κB-inducible genes, reduced cell growth, and compromised tumorigenic ability as compared with WT-YBX1. Taken together, we provide the first evidence that YBX1 functions as a tumor promoter via NF-κB activation, and phosphorylation of S165 of YBX1 is critical for this function. Therefore, our important discovery may lead to blocking S165 phosphorylation as a potential therapeutic strategy to treat colon cancer.",
keywords = "Colon cancer, NF-κB, Phosphorylation, Serine, YBX1",
author = "Lakshmi Prabhu and Rasika Mundade and Benlian Wang and Han Wei and Hartley, {Antja Voy} and Matthew Martin and Kyle McElyea and Temm, {Constance J.} and George Sandusky and Yunlong Liu and Tao Lu",
year = "2015",
doi = "10.18632/oncotarget.5120",
language = "English (US)",
volume = "6",
pages = "29396--29412",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "30",

}

TY - JOUR

T1 - Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer

AU - Prabhu, Lakshmi

AU - Mundade, Rasika

AU - Wang, Benlian

AU - Wei, Han

AU - Hartley, Antja Voy

AU - Martin, Matthew

AU - McElyea, Kyle

AU - Temm, Constance J.

AU - Sandusky, George

AU - Liu, Yunlong

AU - Lu, Tao

PY - 2015

Y1 - 2015

N2 - Y-box binding protein 1 [YBX1] is a multifunctional protein known to facilitate many of the hallmarks of cancer. Elevated levels of YBX1 protein are highly correlated with cancer progression, making it an excellent marker in cancer. The connection between YBX1 and the important nuclear factor κB [NF-κB] has never been reported. Here, we show that overexpression of wild type YBX1 [WT-YBX1] activates NF-κB, suggesting that YBX1 is a potential NF-κB activator. Furthermore, using mass spectrometry analysis we identified novel phosphorylation of serine 165 [S165] on YBX1. Overexpression of the S165A-YBX1 mutant in either HEK293 cells or colon cancer HT29 cells showed dramatically reduced NF-κB activating ability as compared with that of WT-YBX1, confirming that S165 phosphorylation is critical for the activation of NF-κB by YBX1. We also show that expression of the S165A-YBX1 mutant dramatically decreased the expression of NF-κB-inducible genes, reduced cell growth, and compromised tumorigenic ability as compared with WT-YBX1. Taken together, we provide the first evidence that YBX1 functions as a tumor promoter via NF-κB activation, and phosphorylation of S165 of YBX1 is critical for this function. Therefore, our important discovery may lead to blocking S165 phosphorylation as a potential therapeutic strategy to treat colon cancer.

AB - Y-box binding protein 1 [YBX1] is a multifunctional protein known to facilitate many of the hallmarks of cancer. Elevated levels of YBX1 protein are highly correlated with cancer progression, making it an excellent marker in cancer. The connection between YBX1 and the important nuclear factor κB [NF-κB] has never been reported. Here, we show that overexpression of wild type YBX1 [WT-YBX1] activates NF-κB, suggesting that YBX1 is a potential NF-κB activator. Furthermore, using mass spectrometry analysis we identified novel phosphorylation of serine 165 [S165] on YBX1. Overexpression of the S165A-YBX1 mutant in either HEK293 cells or colon cancer HT29 cells showed dramatically reduced NF-κB activating ability as compared with that of WT-YBX1, confirming that S165 phosphorylation is critical for the activation of NF-κB by YBX1. We also show that expression of the S165A-YBX1 mutant dramatically decreased the expression of NF-κB-inducible genes, reduced cell growth, and compromised tumorigenic ability as compared with WT-YBX1. Taken together, we provide the first evidence that YBX1 functions as a tumor promoter via NF-κB activation, and phosphorylation of S165 of YBX1 is critical for this function. Therefore, our important discovery may lead to blocking S165 phosphorylation as a potential therapeutic strategy to treat colon cancer.

KW - Colon cancer

KW - NF-κB

KW - Phosphorylation

KW - Serine

KW - YBX1

UR - http://www.scopus.com/inward/record.url?scp=84945124567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945124567&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.5120

DO - 10.18632/oncotarget.5120

M3 - Article

C2 - 26318844

AN - SCOPUS:84945124567

VL - 6

SP - 29396

EP - 29412

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 30

ER -